FDX1 and nonpapillary renal cell carcinoma: Combined with the results based on in silico analysis, in this section, we first verified the differential expression at the RNA and protein levels, which indicated that ccRCC tumor tissues had a significantly dysregulated FDX1 expression level (Figure 11A–C).